Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Old player, new partner: EGFRvIII and cytokine receptor signaling in glioblastoma

The brain cancer glioblastoma relies on aberrant epidermal growth factor receptor (EGFRvIII) signaling for tumorigenesis. An essential co-receptor and feed-forward circuit maintain signaling in this deadly disease.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: OSMR is an obligate EGFRvIII co-receptor that defines a feed-forward mechanism with EGFRvIII and STAT3 in glioblastoma pathogenesis.

References

  1. Brennan, C.W. et al. Cell 155, 462–477 (2013).

    Article  CAS  Google Scholar 

  2. Cloughesy, T.F., Cavenee, W.K. & Mischel, P.S. Annu. Rev. Pathol. 9, 1–25 (2014).

    Article  CAS  Google Scholar 

  3. Jahani-Asl, A. et al. Nat. Neurosci. 19, 798–806 (2016).

    Article  CAS  Google Scholar 

  4. Lawrence, M.S. et al. Nature 505, 495–501 (2014).

    Article  CAS  Google Scholar 

  5. Furnari, F.B., Cloughesy, T.F., Cavenee, W.K. & Mischel, P.S. Nat. Rev. Cancer 15, 302–310 (2015).

    Article  CAS  Google Scholar 

  6. Liu, F. et al. Mol. Cell 60, 307–318 (2015).

    Article  CAS  Google Scholar 

  7. Vivanco, I. et al. Cancer Discov. 2, 458–471 (2012).

    Article  CAS  Google Scholar 

  8. Kovacs, E., Zorn, J.A., Huang, Y., Barros, T. & Kuriyan, J. Annu. Rev. Biochem. 84, 739–764 (2015).

    Article  CAS  Google Scholar 

  9. Fan, Q.-W. et al. Cancer Cell 24, 438–449 (2013).

    Article  CAS  Google Scholar 

  10. Darnell, J.E. Jr., Kerr, I.M. & Stark, G.R. Science 264, 1415–1421 (1994).

    Article  CAS  Google Scholar 

  11. Lo, H.-W., Cao, X., Zhu, H. & Ali-Osman, F. Clin. Cancer Res. 14, 6042–6054 (2008).

    Article  CAS  Google Scholar 

  12. de la Iglesia, N. et al. Genes Dev. 22, 449–462 (2008).

    Article  CAS  Google Scholar 

  13. Bao, S. et al. Nature 444, 756–760 (2006).

    Article  CAS  Google Scholar 

  14. Patel, A.P. et al. Science 344, 1396–1401 (2014).

    Article  CAS  Google Scholar 

  15. Caffarel, M.M. & Coleman, N. J. Pathol. 232, 386–390 (2014).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Paul S Mischel.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Villa, G., Mischel, P. Old player, new partner: EGFRvIII and cytokine receptor signaling in glioblastoma. Nat Neurosci 19, 765–767 (2016). https://doi.org/10.1038/nn.4302

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nn.4302

This article is cited by

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer